Detection Technology

Detection Technology Plc company announcement 5 March 2026 at 10:00 (EET)

Detection Technology's annual review, financial statements and CG statement 2025 published

Detection Technology Plc's annual review and financial statements 2025 have been published. The reports are available on the company's website (Annual review 2025 - Detection Technology) and attached to this release. The annual review and the financial statements are available in Finnish and English.

Today, Detection Technology has also published its Corporate Governance Statement for 2025. The CG Statement is available in English at https://www.deetee.com/corporate-governance/.

Detection Technology Plc
Board of Directors

Further information
Hannu Martola, President and CEO
+358 500 449 475, hannu.martola@deetee.com

Nordea is the company's Certified Advisor under the Nasdaq First North GM rules, +358 9 5300 6774

Detection Technology is a global provider of X-ray detector solutions and services for medical, security, and industrial applications. The company's solutions range from sensor components to optimized detector subsystems with ASICs, electronics, mechanics, software, and algorithms. It has sites in Finland, China, France, India, and the US. The company's shares are listed on Nasdaq First North Growth Market Finland under the ticker symbol DETEC.

Circulation: Nasdaq Helsinki, key media, www.deetee.com

Detection Technology Plc company announcement 5 March 2026 at 10:00 (EET)

Notice to the Annual General Meeting of Detection Technology Plc

Notice is given to the shareholders of Detection Technology Plc of the Annual General Meeting to be held at Aalto University's campus in Otaniemi, Finland, Dipoli's Lumituuli auditorium, address Otakaari 24, Espoo on Thursday 26 March 2026 at 15:00 (EET). The language of the Annual General Meeting shall be Finnish.

The reception of persons who have registered for the meeting and distribution of voting tickets will commence at the meeting venue at 14:00 (EET).

A. Matters on the Agenda of the General Meeting

The following matters will be considered at the General Meeting:

1. Opening of the meeting

2. Calling the meeting to order

3. Election of persons to scrutinise the minutes and to supervise the counting of votes

4. Recording the legality of the meeting

5. Recording the attendance at the meeting and adoption of the list of votes

6. Presentation of the Financial Statements, the Report of the Board of Directors and the Auditor's Report for the year 2025

Review by the President and CEO

7. Adoption of the Financial Statements, including the adoption of the Consolidated Financial Statements

8. Resolution on the use of the profit shown on the balance sheet and the distribution of funds

The Board of Directors proposes to the Annual General Meeting that, based on the adopted financial statements for 2025, a dividend of EUR 0.30 per share be paid.

The dividend shall be paid to a shareholder who is registered in the company's register of shareholders, maintained by Euroclear Finland Ltd, on the record date for payment, 30 March 2026.

The Board of Directors proposes to the Annual General Meeting that the dividend be paid on 8 April 2026.

9. Resolution on the discharge of the members of the Board of Directors and the CEO from liability

10. Resolution on the remuneration of the members of the Board of Directors

The Shareholders' Nomination Board of Detection Technology Plc (the Nomination Board) proposes that the annual fixed remuneration of the Board of Directors would remain unchanged and would be as follows: annual fee of EUR 69,000 (2025: EUR 69,000) to be paid to the Chair, EUR 51,000 (2025: EUR 51,000) to the Vice Chair, and EUR 39,000 (2025: EUR 39,000) to other members of the Board of Directors.

An elected member of the Board of Directors may, at their discretion, choose to receive the annual fixed remuneration partly in company shares and partly in cash so that approximately 40% of the annual fixed remuneration is paid in Detection Technology Plc's shares. The number of shares forming the above remuneration portion, which would be payable in shares, will be determined based on the share value in the stock exchange trading maintained by Nasdaq Helsinki Ltd, calculated as the trade volume weighted average quotation of the share during the one-month period immediately following the date on which the interim report of January-March 2026 of the company is published.

The Nomination Board proposes that the meeting-specific fees payable for each board meeting remain unchanged and would be as follows: for each meeting held in the home country of the respective member, EUR 1,000 (2025: EUR 1,000) to the Chair of the Board of Directors and EUR 500 (2025: EUR 500) to other members of the Board of Directors, and for each meeting held elsewhere than in the home country of the respective member, EUR 1,500 (2025: EUR 1,500) to the Chair of the Board of Directors and EUR 1,000 (2025: EUR 1,000) to other members of the Board of Directors.

In addition, the Nomination Board proposes that the members of the Audit Committee and the Remuneration Committee would be paid a meeting-specific fee of EUR 500 (2025: EUR 500) per meeting.

The travel expenses of the members of the Board of Directors are compensated in accordance with the company's travel policy.

11. Resolution on the remuneration of the Auditor

The Board of Directors proposes, upon the proposal by the Audit Committee, that the remuneration and travel expenses for the Auditor to be elected be paid according to the Auditor's reasonable invoice.

12. Resolution on the number of members of the Board of Directors

The Nomination Board proposes to the Annual General Meeting that the number of members of the Board of Directors would be six (6).

13. Election of members of the Board of Directors

The Nomination Board proposes that Marion Björkstén, Amy Chen, Richard Ingram, Henrik Roos, Jyrki Vainionpää and Antti Vasara would be re-elected members of the Board of Directors. All candidates have given their consent to the election.

All candidates are independent of the company. The candidates are also independent of Detection Technology Plc's significant shareholders, apart from Marion Björkstén, who acts as Chair of the Supervisory Board of A. Ahlström Oy, and Jyrki Vainionpää, who acts as President and CEO of A. Ahlström Oy. The largest shareholder of Detection Technology Plc, Ahlstrom Capital BV; is a group company of A. Ahlström Oy.

The Nomination Board recommends that Antti Vasara is elected Chair of the Board of Directors.

Presentations of the persons nominated for the Board of Directors are available at Detection Technology Plc's website.

14. Election of the Auditor

The Board of Directors proposes, as recommended by the Board of Directors' Audit Committee, that Authorised Public Accounting firm KPMG Oy Ab is elected as the Auditor of the company for the following term of office ending at the conclusion of the next Annual General Meeting. KPMG Oy Ab has informed that, if elected as the Auditor of the company, Authorised Public Accountant Petri Kettunen will act as the Responsible Auditor.

15. Authorisation to the Board of Directors to decide on the repurchase of own shares

The Board of Directors proposes that the Annual General Meeting authorises the Board of Directors to resolve on the repurchase of a maximum of 732,781 shares in the company in one or several tranches by using funds in the unrestricted shareholders' equity. The number corresponds to approximately 5% of the current number of all shares in the company. The own shares can be repurchased otherwise than in proportion to the shareholdings of the shareholders, if the Board of Directors deems that there are weighty financial reasons for such directed repurchase, in public trading arranged by Nasdaq Finland Ltd for the market price formed at the moment of purchase.

It is proposed that the authorisation be valid until the closing of the next Annual General Meeting, however, no longer than until 30 June 2027. If this authorisation is granted, it will revoke all previous unused authorisations to resolve on the repurchase of own shares.

16. Authorisation of the Board of Directors to resolve on a share issue and an issue of special rights entitling to shares

The Board of Directors proposes that the Annual General Meeting authorises the Board of Directors to resolve on the issuance of shares and the issuance of special rights entitling to shares as referred to in Chapter 10 Section 1 of the Finnish Limited Liability Companies Act in one or several parts, either against payment or without payment. The aggregate number of shares to be issued, including the shares to be received based on special rights, shall not exceed 1,465,563 shares, which corresponds to approximately 10% of the current number of all shares in the company. The Board of Directors may resolve to issue either new shares or to transfer treasury shares potentially held by the company.

The new shares and the special rights referred to in Chapter 10 Section 1 of the Finnish Limited Liability Companies Act may be issued and transferred to the shareholders in proportion to their current shareholdings in the company or in deviation from the shareholders' pre-emptive rights by way of a directed issue if there is a weighty financial reason for the company to do so. The deviation from the shareholders' pre-emptive rights may be carried out, for example in order to develop the company's capital structure, to finance or carry out acquisitions, investments or other business transactions, or to use the shares for an incentive scheme. A directed share issue may be executed without consideration only if there is an especially weighty financial reason for the company to do so, taking the interests of all its shareholders into account.

The Board of Directors is also authorised to decide on a share issue to the company itself without consideration so that the own shares held by the company after the issue do not exceed 10% of all shares in the company. The own shares held by the company and its subsidiaries shall be included in the number of shares as set out in Chapter 15 Section 11 Subsection 1 of the Finnish Limited Liability Companies Act.

The Board of Directors is authorised to decide on all other matters related to the issuance of shares and special rights.

It is proposed that the authorisation be valid until the closing of the next Annual General Meeting, however, no longer than until 30 June 2027. If this authorisation is granted, it will revoke all previous unused authorisations of the Board of Directors to resolve on the issuance of shares and the issuance of special rights entitling to shares.

17. Closing of the meeting
 

B. Documents of the Annual General Meeting

The proposals for the resolutions on the matters on the agenda of the Annual General Meeting set out above as well as this notice are available on Detection Technology Plc's website at www.deetee.com. The Financial Statements, the Report of the Board of Directors and the Auditor's Report of Detection Technology Plc will be available on the above-mentioned website no later than Thursday, 5 March 2026. The proposals for the resolutions and the other above-mentioned documents are also on view at the Annual General Meeting.

The minutes of the Annual General Meeting will be available on the above-mentioned website no later than 9 April 2026.
 

C. Instructions for the Participants in the Annual General Meeting

1. Shareholders registered in the shareholders' register

Each shareholder who is registered on 16 March 2026 (the record date of the Annual General Meeting) in the shareholders' register of the company held by Euroclear Finland Ltd, has the right to participate in the Annual General Meeting. A shareholder whose shares are registered on their personal Finnish book-entry account, is registered in the shareholders' register of the company.

Changes in shareholdings occurring after the record date of the Annual General Meeting shall not affect the right to attend the Annual General Meeting or the number of votes of the shareholder.

A shareholder who is registered in the shareholders' register of the company and who wants to participate in the Annual General Meeting, shall register for the meeting at the latest by 10:00 (EET) on Monday, 23 March 2026 by giving prior notice of participation, which shall be received by the company no later than the above-mentioned time.

Such notice can be given:

a) through the notice link on the company's website www.deetee.com/ir-highlights;

b) through email to investors@deetee.com; or

c) by regular mail to Detection Technology Plc, A Grid, Otakaari 5A, 02150 Espoo, Finland.

In connection with the registration, a shareholder shall notify their name, personal identification number or Business ID, address, telephone number and the name of a possible assistant or proxy representative and the personal identification number of a proxy representative. The personal data given to Detection Technology Plc is used only in connection with the Annual General Meeting and with the processing of related registrations.

The shareholder, their authorised representative or proxy representative shall, where necessary, be able to prove their identity and/or right of representation at the meeting.

2. Holders of Nominee Registered Shares

A holder of nominee registered shares has the right to participate in the Annual General Meeting by virtue of such shares based on which he/she would be entitled to be registered in the shareholders' register of the company held by Euroclear Finland Ltd on 16 March 2026 (the record date of the Annual General Meeting). The right to participate in the Annual General Meeting requires, in addition, that the shareholder has been registered in the temporary shareholders' register held by Euroclear Finland Ltd on the basis of such shares at the latest by 10:00 (EET) on Monday, 23 March 2026. As regards nominee registered shares, this constitutes due registration for the Annual General Meeting.

A holder of nominee registered shares is advised to request all necessary instructions regarding the registration in the temporary shareholders' register of the company, the issuing of proxy documents and registration for the Annual General Meeting from their custodian bank without delay. The account management organisation of the custodian bank has to register a holder of nominee registered shares, who wants to participate in the Annual General Meeting, into the temporary shareholders' register of the company at the latest by the time stated above.

3. Proxy representatives and powers of attorney

The shareholders may participate in the Annual General Meeting and exercise their rights at the meeting by way of proxy representation.

A proxy representative shall produce a dated proxy document or otherwise in a reliable manner demonstrate their right to represent the shareholder at the Annual General Meeting. When a shareholder participates in the Annual General Meeting by means of several proxy representatives representing the shareholder with shares at different securities accounts, the shares by which each proxy representative represents the shareholder shall be identified in connection with the registration for the Annual General Meeting.

Any proxy documents should be delivered either as a scanned copy to investors@deetee.com or by mail to Detection Technology Plc, A Grid, Otakaari 5A, 02150 Espoo, Finland before the end of the registration period on 23 March 2026 at 10:00 (EET). In addition to providing the proxy documents, shareholders or their proxy representatives are also required to register to the Annual General Meeting in the manner instructed in this notice.

As an alternative to a traditional proxy document, a shareholder may authorise a proxy representative by using the Suomi.fi e-authorisation service. The proxy representative is authorised via the Suomi.fi service at www.suomi.fi/e-authorizations (authorisation for `Representation at the General Meeting'). In the General Meeting registration service, the proxy representative must identify themselves by using strong electronic identification, after which they can register on behalf of the shareholder they represent. Strong electronic identification requires Finnish online banking credentials or a mobile certificate. For more information on e-authorisation, please see www.suomi.fi/e-authorizations.

4. Other instructions and information

Pursuant to Chapter 5 Section 25 of the Finnish Limited Liability Companies Act, a shareholder or their representative who is present at the Annual General Meeting has the right to request information with respect to the matters to be considered at the meeting.

On the date of this notice to the Annual General Meeting, 5 March 2026, the total number of shares and votes in Detection Technology Plc is 14,655,630.

Detection Technology Plc

Board of Directors
 

Further information

Hannu Martola, President and CEO
+358 500 449 475, hannu.martola@deetee.com

Nordea is the company's Certified Advisor under the Nasdaq First North GM rules, +358 9 5300 6774

Detection Technology is a global provider of X-ray detector solutions and services for medical, security, and industrial applications. The company's solutions range from sensor components to optimised detector subsystems with ASICs, electronics, mechanics, software, and algorithms. It has sites in Finland, China, France, India, and the US. The company's shares are listed on Nasdaq First North Growth Market Finland under the ticker symbol DETEC.

Distribution: Nasdaq Helsinki, key media, www.deetee.com

Detection Technology Plc company announcement 5 March 2026 at 10:00 (EET)

Detection Technology's Board decided on a Performance Share Plan 2026-2028

The Board of Directors of Detection Technology Plc decided on a Performance Share Plan 2026-2028 (PSP 2026-2028). The performance period of the PSP 2026-2028 program has started in the beginning of January 2026 and will expire at the end of the year 2028. The potential awards under the performance share plan will be paid during H1 2029 as listed shares of Detection Technology.

The primary performance measure on the basis of which the potential share rewards under the PSP 2026-2028 program will be paid is the total shareholder return (absolute TSR) of Detection Technology's share. In addition, performance is evaluated with a sustainability metric, which is connected to the reduction of carbon dioxide emissions.

If all the performance targets set for the PSP 2026-2028 program are fully achieved, the aggregate maximum number of shares to be paid as a reward under the plan is approximately 279,600 shares (gross earnings before the applicable withholding tax). Approximately 60 people, including the members of Detection Technology's management group, are eligible to participate in the PSP 2026-2028 program.

The program is a part of Detection Technology's long-term incentive scheme for management and other key employees, which was established in 2022. The performance share plan consists of separate stock award plans, which the company's Board of Directors resolves each year.

The performance period of the PSP 2023-2025 program started at the beginning of January 2023 and ended at the end of 2025. The performance period of the PSP 2024-2026 program started at the beginning of January 2024 and will finish at the end of 2026. The performance period of the PSP 2025-2027 program started at the beginning of January 2025 and will finish at the end of 2027.

The objective of the performance share plan is to align the interests of Detection Technology's management and key employees with those of the company's shareholders and, thus, to promote shareholder value creation in the long term. In addition, the aim is to commit the management and key employees to achieving Detection Technology's strategic targets.

Each plan comprises a performance period followed by the payment of the potential share rewards in listed shares of Detection Technology. The payment of the rewards is subject to the achievement of the performance targets set by the Board of Directors for the respective plan.

Other terms

The maximum number of shares rewarded to the participants based on PSP is limited by a cap which is linked to Detection Technology's share price development with a multiplier set by the Board of Directors.

If the individual's employment with Detection Technology terminates before the payment of the reward, the individual is not, as a main rule, entitled to any reward based on the respective plan.

Detection Technology applies a share ownership recommendation to the members of the company's management group. According to the recommendation, each member of Detection Technology's management group is expected to accumulate and retain in their ownership at least half of the shares received under the share-based incentive plans of the company until the value of their share ownership in the company corresponds to at least their annual gross base salary.

The Board of Directors, Detection Technology Plc

Further information
Hannu Martola, President and CEO
+358 500 449 475, hannu.martola@deetee.com

Nordea is the company's Certified Advisor under the Nasdaq First North GM rules, +358 9 5300 6774

Detection Technology is a global provider of X-ray detector solutions and services for medical, security, and industrial applications. The company's solutions range from sensor components to optimized detector subsystems with ASICs, electronics, mechanics, software, and algorithms. It has sites in Finland, China, France, India, and the US. The company's shares are listed on Nasdaq First North Growth Market Finland under the ticker symbol DETEC.

Circulation: Nasdaq Helsinki, key media, www.deetee.com

Detection Technology Plc company announcement 10 February 2026 at 08:00 (EET)

Detection Technology: Notification of change in holdings according to Chapter 9, Section 5 of the Securities Markets Act

In accordance with Chapter 9, Section 5 of the Securities Markets Act, Detection Technology Plc has received a notification from OP-Rahastoyhtiö Oy. According to the notification, the combined share of the funds it manages in Detection Technology's shares and votes has fallen below the 5% flagging threshold on 6 February 2026.
 

Total positions of person subject to the notification obligation

Notified details of the resulting situation on the date on which the threshold was crossed

A: Shares and voting rights

Information in relation to the person subject to the notification obligation

Full chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held starting with the ultimate controlling natural person or legal entity.

Detection Technology Plc

Further information

Hannu Martola, President and CEO
+358 500 449 475, hannu.martola@deetee.com

Nordea is the company's Certified Advisor under the Nasdaq First North GM rules, +358 9 5300 6774

Detection Technology is a global provider of X-ray detector solutions and services for medical, security, and industrial applications. The company's solutions range from sensor components to optimized detector subsystems with ASICs, electronics, mechanics, software, and algorithms. It has sites in Finland, China, France, India, and the US. The company's shares are listed on Nasdaq First North Growth Market Finland under the ticker symbol DETEC.

Distribution: Nasdaq Helsinki, key media, www.deetee.com

Detection Technology Plc company announcement 5 February 2026 at 09:00 (EET)

DETECTION TECHNOLOGY PLC FINANCIAL STATEMENTS REVIEW JANUARY-DECEMBER 2025

Detection Technology Q4 2025: A stable year-end, outlook strengthened

October-December 2025 highlights

• Net sales decreased by -6.1% to EUR 29.7 million (31.6)
• Net sales of Americas increased by 1.8% to EUR 2.2 million (2.1)
• Net sales of APAC (Asia-Pacific) decreased by -4.4% to EUR 19.6 million (20.5)
• Net sales of EMEIA (Europe, Middle East, India and Africa) decreased by -11.8% to EUR 7.9 million (9.0)
• Net sales of industrial applications decreased by -6.6% to EUR 4.8 million (5.2)
• Net sales of medical applications increased by 19.1% to EUR 14.9 million (12.5)
• Net sales of security applications decreased by -28.5% to EUR 10.0 million (13.9)
• Operating profit (EBITA) was EUR 3.7 million (5.2)
• Operating margin (EBITA-%) was 12.4% of net sales (16.3%)
• Earnings per share were EUR 0.22 (0.28)
• Earnings per share (diluted) were EUR 0.22 (0.28)
• Return on investment (ROI, 12-month rolling) was 9.2% (17.4%)

January-December 2025 highlights

• Net sales decreased by -6.0% to EUR 101.0 million (107.5)
• Net sales of Americas decreased by -21.8% to EUR 5.2 million (6.6)
• Net sales of APAC decreased by -0.2% to EUR 70.4 million (70.5)
• Net sales of EMEIA decreased by -16.2% to EUR 25.5 million (30.4)
• Net sales of industrial applications decreased by -2.2% to EUR 18.6 million (19.0)
• Net sales of medical applications increased by 10.6% to EUR 46.7 million (42.2)
• Net sales of security applications decreased by -22.8% to EUR 35.7 million (46.3)
• Operating profit (EBITA) excluding NRI was EUR 9.6 million (14.9)
• Operating margin (EBITA-%) excluding NRI was 9.5% of net sales (13.9%)
• Operating profit (EBITA) was EUR 9.3 million (14.9)
• Operating margin (EBITA-%) was 9.2% of net sales (13.9%)
• Earnings per share were EUR 0.44 (0.76)
• Earnings per share (diluted) were EUR 0.44 (0.76)
• Dividend EUR 0.30 per share* (0.50)

UNAUDITED (Figures in parentheses refer to the corresponding period of the previous year.) (*The Board of Directors' proposal to the AGM.)

Business outlook

Detection Technology expects double-digit year-on-year net sales growth in Q1 and H1 of 2026.

The geopolitical situation, new U.S. import tariffs, U.S. relations with other countries, material shortages, and price competition especially in China create uncertainty.

Detection Technology aims to increase its sales by at least 10% per annum and to achieve an operating margin (EBITA) of 15% in the medium term.

President and CEO, Hannu Martola:

"Q4 was stable. Sales in medical applications developed well but were not sufficient to drive overall company growth. Sales in security applications declined, but our total net sales, measured at comparable exchange rates, remained flat. Encouragingly, our outlook strengthened, we executed significant product launches, and sales of security applications are increasing. We are well positioned for 2026 and the new strategic period.

Sales in medical applications grew at a double-digit rate, driven by China, while sales in security applications declined across all our main markets due to various one-off events. In the EMEIA region, the decline is explained by a strong comparison period, the after-effects of the aviation 100 ml regulation, our OEM customer's inventory buffer, and a temporary standstill in demand in India despite a recovering market. In contrast, demand in the APAC region remained subdued. Sales for line-scan solutions in industrial applications also remained modest, while sales for TFT flat panel detectors for battery inspection strengthened in the APAC region, where a transition was made to more efficient and more accurate 3D imaging systems. Demand for industrial applications in other regions, in turn, increased, supported by the food industry.

Fiscal 2025 was volatile. Performance was particularly impacted by exchange rate fluctuations, prolonged regulatory approval processes for aviation computed tomography (CT) systems, and the renewal of our customers' product portfolios. On the positive side, the regulatory bottleneck that had slowed aviation CT installations in Europe was resolved, and inventory buffers were unwound. The indirect effects of China's healthcare reform subsided, and demand strengthened. Particularly encouraging and significant for our competitiveness was the 60% annual growth in TFT sales, driven by industrial applications-especially the battery industry-in China. This product portfolio will also drive future growth in medical and defense applications. We have now established a comprehensive product and service portfolio across all digital X-ray detector applications, enabling more stable and predictable growth in the future.

In Q4, our profitability fell short of our target due to weak sales, and a product mix weighted toward medical solutions. In addition, the end of the lifecycle of an analog product family contributed to weaker results.

In November, we launched the DT2030 strategy. Our objective is to outgrow the X-ray detector market by providing data-generating hardware-software solutions that deliver greater customer value and exceptional usability. During the review period, we made product launches supporting this strategy, where algorithms enable both cost savings and improved data management.

We are delighted and proud to have been named GE HealthCare's Supplier of the Year 2025 among several thousand companies. This recognition reflects our position as a long-term, strategic, and trusted partner that holistically supports our customers' business and advances people's health. Other significant achievements were receiving the EcoVadis rating and Bronze Medal in our very first assessment, and the commissioning of our new India factory and the first customer deliveries from the facility.

Our outlook is good. We expect sales to grow across all main applications and all geographical regions in Q1, and we estimate total net sales to grow at a double-digit rate both in Q1 and in the first half of 2026."

Key figures

Q4 2025 webcast

Hannu Martola, the President and CEO of Detection Technology, will present the Q4 and January-December 2025 financial performance and events to analysts, investors, and media at a webcast. The live webcast in English will begin on 5 February 2026 at 13:00 (EET).

A link to the webcast is available on the company's website (investors, webcasts). A recording of the webcast will be available later on the same webcasts page.

Join the webcast >

This release is a summary of Detection Technology's financial statements review January-December 2025. The complete report can be found attached to the release and on the company's website.

Board of Directors, Detection Technology Plc

Further information

President and CEO Hannu Martola will be available for interviews and further information on the release date at 9:00-11:00 (EET).

Hannu Martola, President and CEO
+358 500 449 475, hannu.martola@deetee.com

Nordea is the company's Certified Advisor under the Nasdaq First North GM rules, +358 9 5300 6774

Detection Technology is a global provider of X-ray detector solutions and services for medical, security, and industrial applications. The company's solutions range from sensor components to optimized detector subsystems with ASICs, electronics, mechanics, software, and algorithms. It has sites in Finland, China, France, India, and the US. The company's shares are listed on Nasdaq First North Growth Market Finland under the ticker symbol DETEC.

Distribution: Nasdaq Helsinki, key media, www.deetee.com

Detection Technology Plc company announcement 29 January 2026 at 16:30 (EET)

Proposals of the Shareholders' Nomination Board of Detection Technology to the Annual General Meeting 2026

Proposal on the number of the members, on the composition, and on the Chair of the Board of Directors

The Shareholders' Nomination Board of Detection Technology Plc (Nomination Board) proposes to the Annual General Meeting 2026 that the number of members of the Board of Directors would be six (6).

The Nomination Board proposes that Marion Björkstén, Amy Chen, Richard Ingram, Henrik Roos, Jyrki Vainionpää and Antti Vasara would be re-elected members of the Board of Directors. All candidates have given their consent to the election.

All candidates are independent of the company. The candidates are also independent of Detection Technology Plc's significant shareholders, apart from Marion Björkstén, who acts as a Chair of the Supervisory Board of A. Ahlström Oy, and Jyrki Vainionpää, who acts as a President and CEO of A. Ahlström Oy. The largest shareholder of Detection Technology Plc, Ahlstrom Capital BV is a group company of A. Ahlström Oy.

The Nomination Board recommends that Antti Vasara is elected Chair of the Board of Directors.

Proposal on the remuneration of the Board of Directors

The Nomination Board proposes that the annual fixed remuneration of the Board of Directors would remain unchanged and would be as follows: annual fee of EUR 69,000 (2025: EUR 69,000) to be paid to the Chair, EUR 51,000 (2025: EUR 51,000) to the Vice Chair, and EUR 39,000 (2025: EUR 39,000) to other members of the Board of Directors.

An elected member of the Board of Directors may, at his/her discretion, choose to receive the annual fixed remuneration partly in company shares and partly in cash so that approximately 40% of the annual fixed remuneration is paid in Detection Technology Plc's shares. The number of shares forming the above remuneration portion, which would be payable in shares, will be determined based on the share value in the stock exchange trading maintained by Nasdaq Helsinki Ltd, calculated as the trade volume weighted average quotation of the share during the one-month period immediately following the date on which the interim report of January-March 2026 of the company is published.

The Nomination Board proposes that the meeting-specific fees payable for each board meeting remain unchanged and would be as follows: for each meeting held in the home country of the respective member, EUR 1,000 to the Chair of the Board of Directors and EUR 500 to other members of the Board of Directors, and for each meeting held elsewhere than in the home country of the respective member, EUR 1,500 to the Chair of the Board of Directors and EUR 1,000 to other members of the Board of Directors.

In addition, the Nomination Board proposes that the members of the audit committee and the remuneration committee would be paid a meeting-specific fee of EUR 500 per meeting.

The travel expenses of the members of the Board of Directors are compensated in accordance with the company's travel policy.

All of the proposals made by the Nomination Board were unanimous. The proposals will be included in the Notice to the Annual General Meeting. The Annual General Meeting is planned to be held on 26 March 2026.

As of 1 September 2025, the Nomination Board has consisted of Peter Seligson, Chair of the Board of A. Ahlström, representing Ahlstrom Capital BV, as Chair of the Nomination Board; and Tomi Viia, Head of Investments at OP, representing the OP mutual funds, and Niina Arkko, Director of Sustainability at Aktia, representing the Aktia mutual funds, as members. The Chair of Detection Technology's Board of Directors, Henrik Roos, has served as an expert member of the Nomination Board.

Detection Technology Plc
 

Further information
Peter Seligson, +31 615 308 635
Chair of the Shareholders' Nomination Board of Detection Technology Plc

Nordea is the company's Certified Advisor under the Nasdaq First North GM rules. +358 9 5300 6774.

Detection Technology is a global provider of X-ray detector solutions and services for medical, security, and industrial applications. The company's solutions range from sensor components to optimized detector subsystems with ASICs, electronics, mechanics, software, and algorithms. It has sites in Finland, China, France, India, and the US. The company's shares are listed on Nasdaq First North Growth Market Finland under the ticker symbol DETEC.

Circulation: Nasdaq Helsinki, main media, www.deetee.com

Detection Technology Plc company announcement 15 January 2026 at 09:00 (EET)

Detection Technology appoints Michael Smith as Vice President, Sales Americas

Detection Technology, a global leader in X-ray detector solutions, has appointed Michael Smith as Vice President, Sales Americas, effective 2 February 2026. He will report to Hannu Martola, President and CEO of Detection Technology, with responsibility for driving growth in the Americas.

Michael Smith brings extensive international sales leadership experience. Since 2020, he has served as Senior Sales Director at KPM Analytics and previously held sales director roles at AMETEK Spectro Scientific from 2016 to 2020. From 1996 to 2015, he worked in Shanghai, holding sales management positions at various companies and gaining broad experience across industrial segments.

"We are very pleased to welcome Michael to our team. He is an accomplished sales leader with extensive experience in industries similar to those of our customers. He has a solid track record of developing key accounts and built sales organizations in vision inspection and analytical instruments industries. His experience and entrepreneurial mindset support the achievement of our growth ambitions in the Americas, in line with our DT2030 strategy," said Hannu Martola, President and CEO.

Detection Technology's global sales and business responsibilities are divided so that Michael Smith, Vice President of Sales, Americas, will assume responsibility for the Americas. Arve Lukander, President EMEIA (Europe, Middle East, India and Africa), will lead the EMEIA region, and Chen Wu, President APAC (Asia-Pacific), will lead the APAC region. The composition of Detection Technology's management group remains unchanged. The change has no impact on the company's financial reporting.

Further information

Hannu Martola, President and CEO
+358 500 449 475, hannu.martola@deetee.com

Nordea is the company's Certified Advisor under the Nasdaq First North GM rules, +358 9 5300 6774

Detection Technology is a global provider of X-ray detector solutions and services for medical, security, and industrial applications. The company's solutions range from sensor components to optimized detector subsystems with ASICs, electronics, mechanics, software, and algorithms. It has sites in Finland, China, France, India, and the US. The company's shares are listed on Nasdaq First North Growth Market Finland under the ticker symbol DETEC.

Distribution: Nasdaq Helsinki, key media, www.deetee.com

Detection Technology Plc Managers' Transactions 26 November 2025 at 17:00 (EET)

Detection Technology Plc - Managers' Transactions

Person subject to the notification requirement

Name: Antti Holopainen

Position: Closely associated person

(1): Person Discharging Managerial Responsibilities In Issuer

Name: Sari Holopainen

Position: Other senior manager

Issuer: Detection Technology Plc

LEI: 743700IXKYKNXJ6BFL39

Notification type: AMENDMENT

Reference number: 131498/5/4

Amendment comment: Venue corrected

____________________________________________

Transaction date: 2025-11-21

Venue: FIRST NORTH GROWTH MARKET FINLAND (FSME)

Instrument type: SHARE

ISIN: FI4000115464

Nature of transaction: ACQUISITION

Transaction details

(1): Volume: 2,000 Unit price: 10.4913 EUR

Aggregated transactions (1):

Volume: 2,000 Volume weighted average price: 10.4913 EUR

Further information
Hannu Martola, President and CEO
+358 500 449 475, hannu.martola@deetee.com

Nordea is the company's Certified Advisor under the Nasdaq First North GM rules, +358 9 5300 6774

Detection Technology is a global provider of X-ray detector solutions and services for medical, security, and industrial applications. The company's solutions range from sensor components to optimized detector subsystems with ASICs, electronics, mechanics, software, and algorithms. It has sites in Finland, China, France, India, and the US. The company's shares are listed on Nasdaq First North Growth Market Finland under the ticker symbol DETEC.

Distribution: Nasdaq Helsinki, key media, www.deetee.com

Detection Technology Plc Managers' Transactions 26 November 2025 at 17:00 (EET)

Detection Technology Plc - Managers' Transactions

Person subject to the notification requirement

Name: Hannu Martola

Position: President and CEO

Issuer: Detection Technology Plc

LEI: 743700IXKYKNXJ6BFL39

Notification type: INITIAL NOTIFICATION

Reference number: 131562/5/6

____________________________________________

Transaction date: 2025-11-21

Venue: FIRST NORTH GROWTH MARKET FINLAND (FSME)

Instrument type: SHARE

ISIN: FI4000115464

Nature of transaction: ACQUISITION

Transaction details

(1): Volume: 1,000 Unit price: 10.5 EUR

(2): Volume: 1,000 Unit price: 10.45 EUR

Aggregated transactions (2):

Volume: 2,000 Volume weighted average price: 10.475 EUR

____________________________________________

Transaction date: 2025-11-24

Venue: FIRST NORTH GROWTH MARKET FINLAND (FSME)

Instrument type: SHARE

ISIN: FI4000115464

Nature of transaction: ACQUISITION

Transaction details

(1): Volume: 1,000 Unit price: 10.75 EUR

Aggregated transactions (1):

Volume: 1,000 Volume weighted average price: 10.75 EUR

Further information
Hannu Martola, President and CEO
+358 500 449 475, hannu.martola@deetee.com

Nordea is the company's Certified Advisor under the Nasdaq First North GM rules, +358 9 5300 6774

Detection Technology is a global provider of X-ray detector solutions and services for medical, security, and industrial applications. The company's solutions range from sensor components to optimized detector subsystems with ASICs, electronics, mechanics, software, and algorithms. It has sites in Finland, China, France, India, and the US. The company's shares are listed on Nasdaq First North Growth Market Finland under the ticker symbol DETEC.

Distribution: Nasdaq Helsinki, key media, www.deetee.com

Detection Technology Plc company announcement 17 November 2025 at 18:00 (EET)

Detection Technology announces its new strategy

Detection Technology Plc has updated its strategy for 2026-2030. In line with the DT2030 strategy, the company aims to outgrow the global X-ray detector market by increasing added-value and focusing on the fastest-growing imaging applications. The company's mid-term financial targets remain unchanged.

The DT2030 strategy builds on the company's core strengths, and its implementation reinforces the company's position as a global leader in X-ray detector solutions. The company seeks new growth through smart, data-generating, and higher value-added solutions to provide its customers with exceptional usability and service experience.

The DT2030 strategic levers are:

• Relentlessly improve current business and operations, and develop capabilities to strengthen profitability and competitiveness
• Drive the TFT X-ray flat panel detector business across different application areas and new geographical markets
• Commercialize more value-added integrated hardware-software solutions to a broader customer base
• Seek new opportunities beyond the current business scope, including photon counting and software solutions
• Being the most trusted partner that drives customer success through exceptional usability
• Elevate performance culture that promotes development and efficiency

Detection Technology's financial targets:

Detection Technology aims to increase its sales by at least 10% per annum and to achieve an operating margin (EBITA) of 15% in the medium term. The company aims to distribute 30-60% of the Group's annual result to shareholders as dividends.

Detection Technology will host the Capital Markets Day on 18 November 2025 starting at 12:30 EET. At the event, the company's new DT2030 strategy will be introduced, along with its business, market developments, growth opportunities, and the technological and production capabilities that strengthen its competitiveness. The event program and registration details are available on the company's website.

Further information

Hannu Martola, President and CEO
+358 500 449 475, hannu.martola@deetee.com

Nordea is the company's Certified Advisor under the Nasdaq First North GM rules, +358 9 5300 6774

Detection Technology is a global provider of X-ray detector solutions and services for medical, security, and industrial applications. The company's solutions range from sensor components to optimized detector subsystems with ASICs, electronics, mechanics, software, and algorithms. It has sites in Finland, China, France, India, and the US. The company's shares are listed on Nasdaq First North Growth Market Finland under the ticker symbol DETEC.

Distribution: Nasdaq Helsinki, key media, www.deetee.com

Detection Technology Plc company announcement 30 October 2025 at 09:00 (EET)

DETECTION TECHNOLOGY PLC BUSINESS REVIEW JANUARY-SEPTEMBER 2025

Detection Technology Q3 2025: A challenging quarter, but the sentiment is improving

July-September 2025 highlights

• Net sales decreased by -8.8% to EUR 24.7 million (27.1)
• Net sales of Americas decreased by -67.7% to EUR 0.6 million (2.0)
• Net sales of APAC (Asia-Pacific) decreased by -5.8% to EUR 16.6 million (17.6)
• Net sales of EMEIA (Europe, Middle East, India and Africa) decreased by -0.2% to EUR 7.5 million (7.5)
• Net sales of industrial applications decreased by -9.2% to EUR 4.5 million (4.9)
• Net sales of medical applications decreased by -4.5% to EUR 10.4 million (10.9)
• Net sales of security applications decreased by -12.8% to EUR 9.8 million (11.3)
• Operating profit (EBITA) excluding non-recurring items (NRI) was EUR 2.8 million (4.2)
• Operating margin (EBITA-%) excluding NRI was 11.4% of net sales (15.3%)
• Operating profit (EBITA) was EUR 2.5 million (4.2)
• Operating margin (EBITA-%) was 10.0% of net sales (15.3%)
• Return on investment (ROI, 12-month rolling) was 12.2% (17.0%)

January-September 2025 highlights

• Net sales decreased by -6.0% to EUR 71.3 million (75.9)
• Net sales of Americas decreased by -32.9% to EUR 3.0 million (4.5)
• Net sales of APAC increased by 1.5% to EUR 50.8 million (50.0)
• Net sales of EMEIA decreased by -18.0% to EUR 17.6 million (21.4)
• Net sales of industrial applications decreased by -0.5% to EUR 13.8 million (13.9)
• Net sales of medical applications increased by 7.1% to EUR 31.8 million (29.7)
• Net sales of security applications decreased by -20.4% to EUR 25.8 million (32.3)
• Operating profit (EBITA) excluding non-recurring items (NRI) was EUR 5.9 million (9.7)
• Operating margin (EBITA-%) excluding NRI was 8.3% of net sales (12.8%)
• Operating profit (EBITA) was EUR 5.6 million (9.7)
• Operating margin (EBITA-%) was 7.8% of net sales (12.8%)

UNAUDITED (Figures in parentheses refer to the corresponding period of the previous year.)

Business outlook

Detection Technology expects a single-digit year-on-year decline in total net sales for Q4 2025 and double-digit growth in Q1 2026.

The geopolitical situation, new U.S. import tariffs, U.S. relations with other countries, China's healthcare reform, and price competition especially in China create uncertainty.

Detection Technology aims to increase its sales by at least 10% per annum and to achieve an operating margin (EBITA) of 15% in the medium term.

President and CEO, Hannu Martola:

The third quarter was as challenging as anticipated. Sales declined across all application areas and geographical markets. Although nearly half of the decrease was due to currency fluctuations, we have taken actions to turn the tide and refocused our resources. We are now moving toward renewed growth as the markets are picking up.

The largest dent in our sales came from security applications. In the Americas, the sales outcome was temporarily weak in Q3, mirroring the sales development of certain key customers. In Europe, a major OEM customer was temporarily depleting its inventories. However, EMEIA's total net sales remained flat as growth in industrial applications offset the decline in security.

The decline in APAC sales was mainly due to the loss of legacy industrial line scanner sales in China because of intense competition. Demand for medical CT (computed tomography) applications continued to grow in China, but material constraints limited our delivery capability. In contrast, sales of security applications increased. Currency exchange rate fluctuations weakened the already soft performance, and total net sales in the APAC region fell slightly short of expectations.

A bright spot of the review period was the strong growth in industrial flat panel detector sales in China. Our position also remained strong in medical and security CT applications in both the APAC and EMEIA regions.

Our profitability improved compared to the previous quarter, and the EBITA margin was double digits. However, it fell short of the comparison period due to the decline in sales and a change in the product mix. We have implemented the necessary cost-saving measures to reach our target level and to focus resources on growth areas that support our long-term strategy. The one-time costs (NRI) related to these changes were EUR 0.3 million.

We believe that we have passed the turning point. Medical and security CT applications are expected to see stronger demand toward the end of the year and into 2026. Industrial demand should remain robust, particularly for our flat panel detectors.

As previously estimated, our Q4 total net sales are expected to decline by a single-digit percentage, which means a flat outcome in comparable currencies. APAC sales are expected to remain at the level of the comparison period, while sales in EMEIA and the Americas are expected to decline. When estimating sales development by main applications, we expect medical and industrial to grow, and security to decline. All regions and applications are nevertheless expected to grow compared to the previous quarter. We expect total net sales in Q4 to grow by double digits compared to Q3. Based on our outlook, Q1 of 2026 will mark a return to growth, and we anticipate double-digit growth in total net sales.

Key figures

The development of net sales

In Q3 2025, Detection Technology's total net sales decreased by -8.8% (10.6%) and amounted to EUR 24.7 (27.1) million. Net sales decreased across all application areas and geographical markets. The decline was mainly due to exchange rate fluctuations and a decrease in demand for security applications.

Sales in security applications declined significantly in the Americas due to the sales development of certain key customers and in Europe as a result of temporary inventory reductions by an OEM customer. However, EMEIA sales remained at the level of the comparison period, supported by growth in industrial sales.

The decline in legacy industrial line-scan application sales had a significant impact on the decrease in APAC sales. Demand for medical CT applications continued to grow in China, but material constraints limited deliveries. Sales in security applications increased, and sales of flat panel detectors strengthened in China, but these were not sufficient to offset the overall loss in APAC sales.

The APAC business unit's net sales decreased by -5.8% (6.5%) to EUR 16.6 (17.6) million. The EMEIA business unit's net sales decreased by -0.2% (33.1%) to EUR 7.5 (7.5) million. The Americas business unit's net sales decreased by -67.7% (-14.5%) to EUR 0.6 (2.0) million. APAC accounted for 67.1% (65.0%) of the company's total net sales, EMEIA 30.2% (27.6%), and the Americas 2.6% (7.4%).

Net sales from medical applications decreased by -4.5% (0.6%) to EUR 10.4 (10.9) million. Net sales from security applications decreased by -12.8% (16.2%) to EUR 9.8 (11.3) million. Net sales from industrial applications decreased by -9.2% (24.0%) to EUR 4.5 (4.9) million. Medical applications accounted for 42.0% (40.2%) of the company's total net sales, security applications 39.8% (41.7%), and industrial applications 18.1% (18.2%).

In Q3, the share of the five largest customers in Detection Technology's total net sales was 53.4% (56.9%).

In January-September 2025, the company's total net sales decreased by -6.0% (4.7%) and were EUR 71.3 (75.9) million. Net sales of APAC increased by 1.5% (3.7%) to EUR 50.8 (50.0) million. Net sales of EMEIA decreased by -18.0% (35.4%) to EUR 17.6 (21.4) million. Net sales of Americas decreased by -32.9% (-46.9%) to EUR 3.0 (4.5) million. APAC accounted for 71.2% (65.9%) of the company's total net sales, EMEIA 24.6% (28.2%), and the Americas 4.2% (5.9%).

Net sales from medical applications increased by 7.1% (-15.9%) to EUR 31.8 (29.7) million. Net sales from security applications decreased by -20.4% (24.1%) to EUR 25.8 (32.3) million. Net sales from industrial applications decreased by -0.5% (24.5%) to EUR 13.8 (13.9) million. Medical applications accounted for 44.6% (39.1%) of the company's total net sales, security applications 36.1% (42.6%), and industrial applications 19.3% (18.3%).

In January-September 2025, the share of the five largest customers in Detection Technology's total net sales was 54.6% (52.1%).

NET SALES BY BUSINESS UNITS

NET SALES BY MAIN APPLICATIONS

Events during the review period

In Q3, Detection Technology took measures to improve profitability and competitiveness. The company adjusted its business to invest in focus areas that strengthen its competitiveness and position in international markets. The purpose of these changes is to streamline and accelerate business operations, enhance the offering, and improve customer focus.

As part of these actions, the company launched change negotiations in Finland under the Act on Co-operation within Undertakings, citing production-related and financial reasons. The negotiations were concluded on 2 September 2025, leading to a total of seven position reductions, an organizational change, and some task reallocations.

The company implemented efficiency and reorganization measures across its global sites. Consequently, a total of six employments were terminated in China. All measures were completed by the end of the review period.

Following the cost-saving program, the company recorded non-recurring items (NRI) totaling EUR 0.3 million (0.0) in Q3. The NRI was related to the reduction in personnel. The company estimates that the measures will result in total cost savings of approximately EUR 0.4 million in H2 of 2025 and EUR 1.5 million in fiscal year 2026.

DT2030 strategy and Capital Markets Day

Detection Technology's current strategy period will end at the close of 2025, and the new strategy will extend through 2030. In line with the DT2030 strategy, the company aims to outgrow the market.

The DT2030 strategy builds on the company's core strengths and reinforces its position as a global leader in X-ray detector solutions. The company focuses on its main application areas and seeks new growth through smarter and higher value-added solutions to provide its customers with exceptional usability and service experience.

Detection Technology will host the Capital Markets Day on 18 November 2025. At the event, the company's new DT2030 strategy will be introduced, along with its business, market developments, growth opportunities, and the technological and production capabilities that strengthen its competitiveness. The event program and registration details are available on the company's website.

Financial statements review 2025

Detection Technology will publish its financial statements review for 2025 on Thursday 5 February 2026.

Board of Directors, Detection Technology Plc

Further information

President and CEO Hannu Martola will be available for interviews and further information on the release date at 9:00-11:00 (EET).

Hannu Martola, President and CEO
+358 500 449 475, hannu.martola@deetee.com

Nordea is the company's Certified Advisor under the Nasdaq First North GM rules, +358 9 5300 6774

Detection Technology is a global provider of X-ray detector solutions and services for medical, security, and industrial applications. The company's solutions range from sensor components to optimized detector subsystems with ASICs, electronics, mechanics, software, and algorithms. It has sites in Finland, China, France, India, and the US. The company's shares are listed on Nasdaq First North Growth Market Finland under the ticker symbol DETEC.

Distribution: Nasdaq Helsinki, key media, www.deetee.com

Detection Technology Plc company announcement 24 September 2025 at 09:00 (EEST)

Detection Technology's financial calendar for 2026

Detection Technology Plc will disclose the following financial releases in 2026:

• Financial statements review 2025: 5 February 2026
• Business review January-March 2026: 23 April 2026
• Half-yearly report January-June 2026: 6 August 2026
• Business review January-September 2026: 29 October 2026

The financial statements and annual review for 2025 will be published on 5 March 2026. The Annual General Meeting is scheduled for 26 March 2026. The Board of Directors of the company will convene the meeting.

Detection Technology's financial calendar can be found from the company's website at https://www.deetee.com/ir-services/.

Further information

Hannu Martola, President and CEO
+358 500 449 475, hannu.martola@deetee.com

Nordea is the company's Certified Advisor under the Nasdaq First North GM rules, +358 9 5300 6774

Detection Technology is a global provider of X-ray detector solutions and services for medical, security, and industrial applications. The company's solutions range from sensor components to optimized detector subsystems with ASICs, electronics, mechanics, software, and algorithms. It has sites in Finland, China, France, India, and the US. The company's shares are listed on Nasdaq First North Growth Market Finland under the ticker symbol DETEC.

Distribution: Nasdaq Helsinki, key media, www.deetee.com

Detection Technology Plc company announcement 15 September 2025 at 09:00 (EEST)

Shareholders' Nomination Board appointed at Detection Technology

A Shareholders' Nomination Board has been appointed at Detection Technology, based on holdings as of 1 September 2025. Chair of the Board of A. Ahlström, Peter Seligson, has been appointed Chair of the Nomination Board as the representative of Ahlstrom Capital BV. Head of Investments at OP Varainhoito, Tomi Viia, representing the OP mutual funds, and Director of Sustainability at Aktia, Niina Arkko, representing the Aktia mutual funds, have been appointed as Members.

Henrik Roos, Chair of Detection Technology's Board of Directors, serves as an expert on the Nomination Board. The organizing meeting of the Nomination Board was held on 12 September 2025.

The Shareholders' Nomination Board is responsible for preparing and presenting proposals to the General Meeting concerning the remuneration and number of members of the Board of Directors, as well as proposals for appointing members of the Board. The Nomination Board will submit its proposals for the next Annual General Meeting (AGM) to the Board of Directors of Detection Technology no later than 30 January 2026.

The Nomination Board consists of three members appointed by the company's three largest shareholders, each of which is entitled to nominate one member. The largest shareholders are determined based on the holdings listed in the shareholders' register of the company maintained by Euroclear Finland Ltd as of the first working day in September preceding the next AGM. The Chair of the Board of Detection Technology serves on the Nomination Board as an expert but is not an official member of the Nomination Board and does not have voting rights.

Detection Technology Plc

Further information

Hannu Martola, President and CEO
+358 500 449 475, hannu.martola@deetee.com

Nordea is the company's Certified Advisor under the Nasdaq First North GM rules, +358 9 5300 6774

Detection Technology is a global provider of X-ray detector solutions and services for medical, security, and industrial applications. The company's solutions range from sensor components to optimized detector subsystems with ASICs, electronics, mechanics, software, and algorithms. It has sites in Finland, China, France, India, and the US. The company's shares are listed on Nasdaq First North Growth Market Finland under the ticker symbol DETEC.

Distribution: Nasdaq Helsinki, key media, www.deetee.com

Detection Technology Plc company announcement 7 August 2025 at 09:00 (EEST)

DETECTION TECHNOLOGY PLC HALF-YEARLY REPORT JANUARY-JUNE 2025

Detection Technology Q2 2025: Sales declined, yet the company's market position remained solid

April-June 2025 highlights

• Net sales decreased by -6.6% to EUR 24.4 million (26.1)
• Net sales of Americas decreased by -5.2% to EUR 1.5 million (1.6)
• Net sales of APAC (Asia-Pacific) increased by 8.6% to EUR 18.2 million (16.7)
• Net sales of EMEIA (Europe, Middle East, India and Africa) decreased by -39.6% to EUR 4.7 million (7.8)
• Net sales of industrial applications increased by 4.2% to EUR 5.6 million (5.3)
• Net sales of medical applications increased by 13.9% to EUR 10.6 million (9.3)
• Net sales of security applications decreased by -28.2% to EUR 8.2 million (11.5)
• Operating profit (EBITA) was EUR 1.7 million (3.3)
• Operating margin (EBITA-%) was 7.0% of net sales (12.7%)
• Return on investment (ROI, 12-month rolling) was 14.7% (13.9%)

January-June 2025 highlights

• Net sales decreased by -4.5% to EUR 46.6 million (48.8)
• Net sales of Americas decreased by -4.8% to EUR 2.4 million (2.5)
• Net sales of APAC increased by 5.5% to EUR 34.2 million (32.4)
• Net sales of EMEIA decreased by -27.5% to EUR 10.1 million (13.9)
• Net sales of industrial applications increased by 4.2% to EUR 9.3 million (8.9)
• Net sales of medical applications increased by 13.8% to EUR 21.4 million (18.8)
• Net sales of security applications decreased by -24.4% to EUR 15.9 million (21.1)
• Operating profit (EBITA) was EUR 3.1 million (5.6)
• Operating margin (EBITA-%) was 6.7% of net sales (11.4%)

UNAUDITED (Figures in parentheses refer to the corresponding period of the previous year.)

Business outlook

Detection Technology expects a single digit year-on-year net sales decline in Q3 and H2 of 2025.

The geopolitical situation, new U.S. import tariffs, U.S. relations with other countries, China's healthcare reform, and price competition especially in China create uncertainty.

Detection Technology aims to increase its sales by at least 10% per annum and to achieve an operating margin (EBITA) of 15% in the medium term.

President and CEO, Hannu Martola:

"Our Q2 total net sales were a disappointment. Security CT system installations nearly halted in Europe, and EMEIA sales declined sharply. Over half of the sales decline was due to currency fluctuations. However, our position in key markets remained stable. We also maintained strong momentum in flat panel detector sales and strategic execution.

Demand for medical CT applications strengthened, particularly in China, where the backlog from healthcare reforms continued to clear. Sales of our flat panel detector portfolio for industrial applications also developed strongly, growing approximately 40% year-on-year in H1.

In contrast, the dip in demand for security applications was deeper than expected, leading to a sharp decline in EMEIA sales. The halt in security CT system installations in aviation in Europe-partly due to the so-called 100 ml liquid rule-weighed on performance. The strong comparison period also added pressure to the topline. Despite softer-than-expected sales, our market position in security CT remained intact.

Lower-than-expected quarterly sales and a less favorable sales mix eroded our profitability. Our profitability development has been unsatisfactory. To that end, appropriate cost measures are now being taken.

In Q2, we rolled out several notable products. Sales of the X-Panel 43108 flat panel detector, launched for single-scan imaging of large components in the automotive, aerospace, and defense industries, have started off successfully. We also introduced the X-Cargo for high-speed, high-energy cargo and industrial imaging. Supporting scanning speeds up to 70 km/h, the solution is already selling well for border security applications.

The expansion of our operations in India is progressing. The production facility has been completed, and the first products have been tested. We also invested in new technology to support long-term innovations and growth.

We are renewing our strategy for the next five-year period. We will deliver smart X-ray detector solutions that drive customer success through exceptional usability to outgrow the market. We continue to work on the strategy details and execution planning.

Looking ahead, we expect demand in both medical and security CT applications to start normalizing. In China, the recovery in medical demand continues following anti-corruption measures, but the new block purchasing model is intensifying competition. The regulatory bottleneck in European aviation will move away, as testing specifications for CT systems have been approved, and the equipment from a certain OEM has been recertified. We expect the security CT sales to be back on track by the end of the year. Industrial demand, particularly in defense, is increasing. However, visibility remains limited due to the impact of new tariffs, ongoing macroeconomic uncertainty, and constrained availability of certain electronic components.

In Q3, the APAC region indicates strengthening medical demand, but our sales are constrained mainly by component availability and therefore will remain stable. Demand for security applications is picking up slowly, leading to flat sales in EMEIA, while sales in the Americas are expected to decline by double digits. Following an estimated 5% currency impact, we expect year-on-year total net sales to decline by a single digit in Q3 and H2 of 2025."

Key figures

Q2 2025 webcast

Hannu Martola, the President and CEO of Detection Technology, will present the Q2 and January-June 2025 financial performance and events to analysts, investors, and media at a webcast. The live webcast in English will begin on 7 August 2025 at 13:00 (EEST).

A link to the webcast is available on the company's website (investors, webcasts). A recording of the webcast will be available later on the same webcasts page.

Join the webcast >

This release is a summary of Detection Technology's half-yearly report January-June 2025. The complete report can be found attached to the release and on the company's website.

Board of Directors, Detection Technology Plc

Further information

President and CEO Hannu Martola will be available for interviews and further information on the release date at 9:00-11:00 (EEST).

Hannu Martola, President and CEO
+358 500 449 475, hannu.martola@deetee.com

Nordea is the company's Certified Advisor under the Nasdaq First North GM rules, +358 9 5300 6774

Detection Technology is a global provider of X-ray detector solutions and services for medical, security, and industrial applications. The company's solutions range from sensor components to optimized detector subsystems with ASICs, electronics, mechanics, software, and algorithms. It has sites in Finland, China, France, India, and the US. The company's shares are listed on Nasdaq First North Growth Market Finland under the ticker symbol DETEC.

Distribution: Nasdaq Helsinki, key media, www.deetee.com

Detection Technology Plc inside information 17 June 2025 at 17:00 (EEST)

Inside information, profit warning: Detection Technology lowers its net sales guidance for Q2 2025

Detection Technology lowers its guidance for Q2 2025 and expects total net sales to decline by high single digits compared to the corresponding period last year. The main reason for this is the postponement of security X-ray system deployments in the EMEIA region (Europe, the Middle East, India, and Africa). The company maintains its net sales guidance for Q3 2025 unchanged.

New business outlook:

Detection Technology expects its total net sales to decline by high single digits year-on-year in Q2 2025 and to remain stable year-on-year in Q3 2025.

Geopolitical situation, new US import tariffs, U.S.-China relations, U.S.-EU relations, global economy, China's healthcare reform, price competition especially in China, the indirect impacts of the war in Ukraine, and events in the Middle East create uncertainty.

Detection Technology aims to increase its sales by at least 10% per annum and to achieve an operating margin (EBITA) of 15% in the medium term.

Previous business outlook (issued on 24 April 2025):

Detection Technology expects its year-on-year total net sales to remain stable in Q2 and Q3 of 2025.

Detection Technology has refined its earlier estimate of double-digit total net sales growth for Q2 2025 (published on 6 February 2025) and now expects sales to be at the same level as in the comparison period. The main reasons for this are exchange rate changes and the postponement of security system deployments.

Geopolitical situation, new US import tariffs, U.S.-China relations, U.S.-EU relations, global economy, China's healthcare reform, price competition especially in China, the indirect impacts of the war in Ukraine, and events in the Middle East create uncertainty.

Detection Technology aims to increase its sales by at least 10% per annum and to achieve an operating margin (EBITA) of 15% in the medium term.

Detection Technology will publish the half-yearly report on 7 August 2025.

Further information

Hannu Martola, President and CEO
+358 500 449 475, hannu.martola@deetee.com

Nordea is the company's Certified Advisor under the Nasdaq First North GM rules, +358 9 5300 6774

Detection Technology is a global provider of X-ray detector solutions and services for medical, security, and industrial applications. The company's solutions range from sensor components to optimized detector subsystems with ASICs, electronics, mechanics, software, and algorithms. It has sites in Finland, China, France, India, and the US. The company's shares are listed on Nasdaq First North Growth Market Finland under the ticker symbol DETEC.

Distribution: Nasdaq Helsinki, key media, www.deetee.com